Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar pyupie0216 (28.38) Submitted: 8/18/2010 5:55:20 PM : Underperform Start Price: $2.44 ACUR Score: +9.14

screen

Report this Post Reply

Featured Broker Partners


Advertisement